In this study, changes such as a significant increase in the number of CD4+ and CD8+ T cells were observed, which led to a decrease in lymphopenia in patients, as well as a significant reduction in all acute inflammatory factors of serum and optimal improvement of pulmonary inflammation in patients. The gene discussed is CD4; the disease is lymphopenia.